|
【结 构 式】 
|
【药物名称】E-7820, ER-68203-00 【化学名称】3-Cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide 【CA登记号】 【 分 子 式 】C17H12N4O2S 【 分 子 量 】336.37479 |
【开发单位】Eisai (Originator) 【药理作用】Oncolytic Drugs, Angiogenesis Inhibitors, Integrin Receptor Antagonists |
合成路线1
The synthesis of intermediate (VIII) can be achieved by following two different routes: 1) Treatment of 2-bromo-5-methylnitrobenzene (I) with vinyl magnesium bromide (II) in THF yields bromoindole derivative (III), which is then converted into carboxylic acid (IV) by means of BuLi and CO2 in THF. Treatment of (IV) with diphenylphosphoryl azide (DPPA) and Et3N converts the carboxylic group into an amine intermediate which is then treated with hot t-BuOH to afford derivative (V). Formylation of (V) by means of DMF, POCl3 and aqueous NaOH provides aldehyde (VI), which is then treated with hydroxylamine (NH2OH), pyridine and N,N'-carbonyldiimidazole (CDI) and then heated with Et3N to furnish cyano derivative (VII). Finally, removal of the Boc group of (VII) by treatment with TFA in CH2Cl2 gives intermediate (VIII). 2) Alternatively, conversion of 5-methyl-2-nitroaniline (IX) into hydrazone derivative (XI) is achieved by first reaction with NaNO2 in hydrochloric acid media followed by condensation with ethyl 2-methylacetoacetate (X) in EtOH and aqueous KOH. Treatment of (XI) with refluxing H3PO4 in xylene yields indole derivative (XII), which is hydrolyzed by means of aqueous NaOH in THF to afford carboxylic acid (XIII). Decarboxylation of (XIII) with CuCO3 in 1,3-dimethyl-2-imidazolidinone furnishes 4-methyl-7-nitro-1H-indole (XIV), which is then formylated by means of DMF, POCl3 and aqueous NaOH to give aldehyde (XV). Conversion of formyl derivative (XV) into cyano derivative (XVI) is achieved by treatment with hydroxylamine (NH2OH), pyridine and N,N'-carbonyldiimidazole (CDI) followed by heating with Et3N. Finally, hydrogenation of the nitro group of (XVI) over PtO2 affords the target intermediate (VIII).
| 【1】 Kamata, J.; Semba, T.; Nara, K.; Ohwa, T.; Hata, N.; Haneda, T.; Funahashi, Y.; Hamaoka, S.; Tsuruoka, A.; Ueda, N.; Wakabayashi, T.; Ozawa, Y.; Yamamoto, Y.; Okabe, T.; Takahashi, K.; Tsukahara, N. (Eisai Co., Ltd.); Sulfonamide-containing indole cpds.. EP 1074542; JP 2000247949; WO 0050395 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 44784 | 1-bromo-4-methyl-2-nitrobenzene | 5326-34-1 | C7H6BrNO2 | 详情 | 详情 |
| (II) | 16524 | bromo(vinyl)magnesium | 1826-67-1 | C2H3BrMg | 详情 | 详情 |
| (III) | 44717 | 7-bromo-4-methyl-1H-indole | C9H8BrN | 详情 | 详情 | |
| (IV) | 44718 | 4-methyl-1H-indole-7-carboxylic acid | C10H9NO2 | 详情 | 详情 | |
| (V) | 44731 | tert-butyl 4-methyl-1H-indol-7-ylcarbamate | C14H18N2O2 | 详情 | 详情 | |
| (VI) | 44734 | tert-butyl 3-formyl-4-methyl-1H-indol-7-ylcarbamate | C15H18N2O3 | 详情 | 详情 | |
| (VII) | 44736 | tert-butyl 3-cyano-4-methyl-1H-indol-7-ylcarbamate | C15H17N3O2 | 详情 | 详情 | |
| (VIII) | 44742 | 7-amino-4-methyl-1H-indole-3-carbonitrile | C10H9N3 | 详情 | 详情 | |
| (IX) | 44745 | 5-methyl-2-nitrophenylamine; 5-methyl-2-nitroaniline | 578-46-1 | C7H8N2O2 | 详情 | 详情 |
| (X) | 10362 | ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate | 609-14-3 | C7H12O3 | 详情 | 详情 |
| (XI) | 44754 | ethyl 2-[(E)-2-(5-methyl-2-nitrophenyl)hydrazono]propanoate | C12H15N3O4 | 详情 | 详情 | |
| (XII) | 44755 | ethyl 4-methyl-7-nitro-1H-indole-2-carboxylate | C12H12N2O4 | 详情 | 详情 | |
| (XIII) | 44756 | 4-methyl-7-nitro-1H-indole-2-carboxylic acid | C10H8N2O4 | 详情 | 详情 | |
| (XIV) | 44757 | 4-methyl-7-nitro-1H-indole | C9H8N2O2 | 详情 | 详情 | |
| (XV) | 44760 | 4-methyl-7-nitro-1H-indole-3-carbaldehyde | C10H8N2O3 | 详情 | 详情 | |
| (XVI) | 44761 | 4-methyl-7-nitro-1H-indole-3-carbonitrile | C10H7N3O2 | 详情 | 详情 |
合成路线2
Synthesis of EN 287632: 3-Cyanoaniline (XVII) is converted into 3-cyanobenzenesulfonyl chloride (XVIII) by first treatment with NaNO2 in H2O/HCl followed by reaction with HOAc saturated with SO2 and CuCl. To obtain the final compound, sulfonyl chloride derivative (XVIII) is condensed with intermediate (VIII) by means of pyridine in THF.
| 【1】 Kamata, J.; Semba, T.; Nara, K.; Ohwa, T.; Hata, N.; Haneda, T.; Funahashi, Y.; Hamaoka, S.; Tsuruoka, A.; Ueda, N.; Wakabayashi, T.; Ozawa, Y.; Yamamoto, Y.; Okabe, T.; Takahashi, K.; Tsukahara, N. (Eisai Co., Ltd.); Sulfonamide-containing indole cpds.. EP 1074542; JP 2000247949; WO 0050395 . |